ArticleBiological research2025
Mitochondrial and lysosomal dysfunctions might be involved in the pathogenesis of the CACNA1A-related neurodevelopmental disorders according to in vitro studies.
Article in Biological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundCACNA1A variants are associated with severe neurodevelopmental disorders (NDDs), but the underlying mechanisms remain unclear. Our goal was to investigate the molecular mechanisms through which these variants lead to intellectual disability (ID), autism spectrum disorder (ASD), epilepsy, and ataxia.
methodsClinical information was collected from six pediatric patients. Molecular experiments were performed on transfected human embryonic kidney and Chinese hamster ovary cells to study the effect of these variants on mitochondrial and lysosomal function. RT-qPCR, Western blot, apoptosis assay, mitochondrial and lysosomal tracker fluorescence intensity, and mitochondrial calcium concentration tests were performed. Additionally, we examined the levels of reactive oxygen species (ROS), adenosine triphosphate (ATP), and mitochondrial enzymes and copy numbers.
resultsWe identified six variants that downregulated CACNA1A mRNA: p.D1644N, p.Y62C, p.G701R, p.R279C, p.R1664Q, and p.L1422Sfs*8. Five variants down-regulated Cav2.1 protein expression, whereas, the p.R279C variant up-regulated it. All variants led to dysfunctions in the autophagy-lysosomal system: p.D1644N, p.R279C, and p.G701R variants blocked the fusion of autophagosomes and lysosomes while p.Y62C, p.R1664Q, and p.L1422Sfs*8 variants displayed increased lysosomal expression. The p.Y62C, p.G701R, p.R279C, p.R1664Q, and p.L1422Sfs*8 variants exhibited defective autophagy. The p.Y62C and p.D1644N variants disrupted mitochondrial function by downregulating mitochondrial enzyme activities and ATP levels, as well as by upregulating mitochondrial copy numbers, calcium levels, and ROS levels. Furthermore, the p.Y62C variant increased mitochondrial expression, fusion, and fission. In contrast, the p.D1644N variant decreased mitochondrial expression, fusion, fission, and mitophagy. The p.G701R, p.R279C, and p.R1664Q variants also interrupted mitochondrial function. These variants down-regulated mitochondrial enzyme activities, fusion and fission, the mitophagy process, and ATP levels while up-regulating mitochondrial copy numbers and ROS levels. The p.L1422Sfs*8 variant increased the expression, fusion and fission of mitochondrial proteins, while decreasing mitochondrial calcium levels and the mitophagy process. The p.R279C variant increased mitochondrial expression and calcium levels while enhancing apoptosis. The p.G701R variant decreased mitochondrial expression and calcium levels while enhancing apoptosis. The p.R1664Q variant increased mitochondrial calcium levels and enhanced apoptosis without changing mitochondrial expression.
conclusionsCACNA1A variants may alter mitochondrial and lysosomal function, resulting in the development of NDDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.